The BRICS IoT implantable cardiac devices market size is expected to reach US$ 11,970.6 million by 2033 from US$ 2,762.0 million in 2024. The market is estimated to record a CAGR of 17.7% from 2025 to 2033.
Executive Summary and BRICS IoT Implantable Cardiac Devices Market Analysis:
The IoT implantable cardiac devices market in BRICS is experiencing significant growth driven by the rising incidence of cardiovascular diseases & arrhythmias, demand for real-time monitoring & early intervention, advancements in device miniaturization & battery life. The IoT implantable cardiac devices market in BRICS reflects the variety and extent of these major economies. These countries together face an increasing prevalence of cardiovascular diseases, which is the result of aging populations, urbanization, and lifestyle changes. Connected pacemakers hold the largest share in the product market, as the demand for rhythm management solutions is increasing. Bluetooth-enabled devices are at the forefront of the technology segment because of their low cost and compatibility with smartphones, which are widely used in BRICS countries. Hospitals and clinics are still the major end-users as they can provide the necessary infrastructure and expertise for implantation and monitoring. The multinational players like Medtronic, Abbott, and Philips are widening their footprints through partnerships with local distributors, while domestic innovators in India, China, and Brazil are coming up with low-cost IoT-enabled solutions customized to meet local needs. The market assessment reveals that BRICS is shifting from traditional cardiac care towards IoT-enabled solutions; thus, the region becomes a vital growth catalyst for worldwide implantable cardiac technologies.
BRICS IoT Implantable Cardiac Devices Market Segmentation Analysis:
Key segments that contributed to the derivation of the IoT implantable cardiac devices market analysis are product, technology, application, and end user.
- By product, the IoT implantable cardiac devices market is segmented into IoT connected pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, cardiac resynchronization therapy devices, and others. IoT connected pacemakers dominated the market in 2024, driven by the rising cardiovascular disease burden across populous BRICS nations.
- By technology, the IoT implantable cardiac devices market is segmented into Bluetooth, cellular, and others. Bluetooth dominated the market in 2024, driven by affordability and compatibility with smartphones widely adopted in BRICS economies.
- In terms of application, the market is segmented into arrhythmia detection, heart failure monitoring, remote pacemaker management, and others. Arrhythmia detection dominated the market in 2024, driven by the increasing need for continuous monitoring in high‑risk populations.
- By end user, the market is segmented into hospitals & clinics, specialty cardiac centers, and others. Hospitals & clinics dominated the market in 2024, driven by reliance on tertiary care centers for advanced cardiac procedures.
BRICS IoT Implantable Cardiac Devices Market Outlook
The BRICS IoT Implantable Cardiac Devices market outlook is characterized by the potential for robust growth that is largely supported by improvements in infrastructure and the adoption of digital health. In these upcoming years, government-supported healthcare reforms, extension of the telecom networks, and the demand for remote monitoring will be the main factors to convince people to adopt these devices. Even if Bluetooth-enabled pacemakers will still be the major product, it is highly probable that cellular-enabled devices, in particular, will be able to get a handful of users as 5G infrastructures become more common in China, India, and Russia. Affordability will be the main factor of strategic investments with regard to the healthcare sector by the use of modular device designs and subscription-based monitoring services, which will be customized for different healthcare systems. The training of healthcare professionals will also be very important to provide the correct implantation and monitoring of the devices. In fact, urban areas like Sao Paulo, Moscow, Mumbai, Beijing, and Johannesburg will be the main drivers of demand. Also, the outlook emphasizes manufacturing hubs of the region, like China and India, which will be able to make products at lower prices and offer them to more people. At large, the BRICS evolution is leading to a scenario where the market will be mainly characterized by affordability, innovation, and local strategies that are in line with different healthcare landscapes.
BRICS IoT Implantable Cardiac Devices Market Country Insights
Based on country, the BRICS IoT implantable cardiac devices market is segmented into Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. China held the largest share in 2024.
Insights at the country level show different adoption patterns across the BRICS countries. China is a leader with massive investments in healthcare infrastructure and strong government support for digital health initiatives. India is a high-potential market; a large population will drive the demand owing to the increasing cardiovascular disease burden; however, affordability and access are still problems. Brazil is focused on telehealth expansion, which is creating demand for IoT-enabled cardiac devices in both urban and rural areas. Russia is slowly embracing IoT-enabled devices, and the healthcare modernization programs backed by the government are helping in this regard. South Africa, with its well-developed private healthcare sector, is expecting increased use of implantable monitors and pacemakers. Local partnerships are very important, as multinational players collaborate with regional distributors and healthcare providers to deal with regulatory complexities and ensure supply chain efficiency. Together, the BRICS countries portray a combination of opportunities, with mature markets setting the benchmarks and emerging ones offering the growth potential. The region's success will depend on making strategies according to local situations, balancing affordability with innovation, and exploiting partnerships to bridge the gaps in infrastructure and expertise.
BRICS IoT Implantable Cardiac Devices Market Company Profiles
Medtronic Plc, GE HealthCare Technologies Inc, Koninklijke Philips NV, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, Biotronik, MicroPort Scientific Corporation, LivaNova PLC, LEPU Medical Technology (Beijing) Co., Ltd., are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
BRICS IoT Implantable Cardiac Devices Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Key Sources Referred:
- World Health Organization (WHO)
- Organisation for Economic Cooperation and Development (OECD)
- The World Bank Group
- Worldometer
- The Lancet
- International Bar Association
- International Trade Administration
- Eurostat
- United Nations Department of Economic and Social Affairs
BRICS IoT Implantable Cardiac Devices Market Strategic Insights
BRICS IoT Implantable Cardiac DevicesMarket Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 2,762.0 Million |
| Market Size by 2033 | US$ 11,970.6 Million |
| CAGR (2025 - 2033) | 17.7% |
| Historical Data | 2022-2023 |
| Forecast period | 2025-2033 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| BRICS | Russia, Brazil, South Africa, India, China, Egypt, Indonesia, United Arab Emirates, Saudi Arabia |
| Market leaders and key company profiles |
|
BRICS IoT Implantable Cardiac Devices Market Country and Regional Insights
